Lung metastasis in soft tissue sarcomas: survival and risk factors using the SEER database

Abstract

Aim: To investigate patients with soft tissue sarcoma (STS) and evaluate (1) factors associated with lung metastases at the time of diagnosis; (2) the impact these factors had on overall survival; and (3) the impact of the metastatic site on survival.

Methods: We utilized the SEER database to analyze data from 14,520 patients diagnosed with STS between 2010 and 2018. Inclusion criteria included histologically confirmed STS of the lower limb, upper limb, or pelvis. Demographic, oncologic, and survival data were extracted, including tumor size, histopathology, AJCC staging, and metastatic status. Univariable and multivariable analyses identified risk factors for lung metastasis and Kaplan-Meier survival analysis was used to assess disease-specific survival (DSS).

Results: Of the 13,372 patients with STS, 7.9% had lung metastases at diagnosis. Undifferentiated pleomorphic sarcoma, leiomyosarcoma, and rhabdomyosarcoma were the most common STS presenting with lung metastasis. Patients who present with STS of the lower extremity, higher grade, and either leiomyosarcoma, spindle cell, or synovial cell sarcoma were more likely to present with lung metastases. Patients with lung metastases had worse survival than patients without metastases. However, survival was better in patients with isolated lung metastases than in those with any combination of lung, bone, brain, and/or liver metastases.

Conclusion: Tumor location, grade, T score, and lymph node involvement were significant risk factors for lung metastasis. A deeper understanding of risk factors for lung metastases presents a new opportunity for investigation in management. As expected, patients who present with lung metastases have worse overall survival.

Keywords

Soft tissue sarcoma / metastasis / lung / SEER

References

[1] White LM,Bell RS.Histologic assessment of peritumoral edema in soft tissue sarcoma.Int J Radiat Oncol Biol Phys2005;61:1439-45

[2] Weitz J,Brennan MF.Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.J Clin Oncol2003;21:2719-25

[3] Soft Tissue Sarcomas: Incidence and Survival Rates in England. Accessed November 8, 2022. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/soft-tissue-sarcoma

[4] Billingsley KG,Jara E.Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.Ann Surg1999;229:602-10; discussion 610 PMCID:PMC1420804

[5] Hong Z,Rhea L,McDonald D.Patterns of extrapulmonary metastases in sarcoma surveillance.Cancers (Basel)2021;13:4669 PMCID:PMC8470859

[6] Yamamoto Y,Kanou T.Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma.Int J Clin Oncol2019;24:863-70

[7] Bauer HC.Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.Acta Orthop Scand1995;66:143-6

[8] Kotilingam D,Lazar AJ.Staging soft tissue sarcoma: evolution and change.CA Cancer J Clin2006;56:282-91; quiz 314

[9] Pastorino U,Ginsberg RJ.A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases.Chest Surg Clin N Am1998;8:197-202

[10] Migliore M.Looking forward lung metastasectomy-do we need a staging system for lung metastases?.Ann Transl Med2016;4:124 PMCID:PMC4828745

[11] Lee RM,Gamboa AC.A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative.J Surg Oncol2021;124:1477-84 PMCID:PMC8595861

[12] Callegaro D,Mariani L,Gronchi A.Soft tissue sarcoma nomograms and their incorporation into practice.Cancer2017;123:2802-20

[13] Hui JY.Epidemiology and Etiology of Sarcomas.Surg Clin North Am2016;96:901-14

[14] Gerrand CH,Wunder JS.The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity.Cancer2003;97:485-92

[15] Edge SB.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.Ann Surg Oncol2010;17:1471-4

[16] Welter S,Bauer S.Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histology.Interact Cardiovasc Thorac Surg2012;15:612-7 PMCID:PMC3445364

[17] Tsuchie H,Nagasawa H.Impact of primary tumor resection on metastasis to the lung in patients with bone and soft-tissue sarcoma.In Vivo2021;35:3467-73 PMCID:PMC8627774

[18] Lindner LH,Sleijfer S.Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).Int J Cancer2018;142:2610-20 PMCID:PMC5947111

[19] Enneking WF,Malawer MM.The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh.Cancer1981;47:1005-22

[20] Pfannschmidt J,Muley T,Hoffmann H.Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients.Ann Thorac Surg2006;81:448-54

[21] Sawamura C,Shimoji T,Okawa A.Lymphadenectomy and histologic subtype affect overall survival of soft tissue sarcoma patients with nodal metastases.Clin Orthop Relat Res2013;471:926-31 PMCID:PMC3563793

[22] Italiano A,Cesne AL.Trends in survival for patients with metastatic soft-tissue sarcoma.Cancer2011;117:1049-54

[23] Collin C,Hajdu S.Localized extremity soft tissue sarcoma: an analysis of factors affecting survival.J Clin Oncol1987;5:601-12

[24] Gaakeer HA,Gortzak E.Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences?.Eur J Surg Oncol1988;14:151-6

[25] Chmiel P,Szumera-Ciećkiewicz A,Czarnecka AM.Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma.Curr Oncol2024;31:307-23 PMCID:PMC10814427

[26] Billingsley KG,Leung DH,Woodruff JM.Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.Cancer1999;85:389-95

[27] Casson AG,Natarajan G.Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma.Cancer1992;69:662-8

[28] Kim S,Wright CD.Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes.Ann Thorac Surg2011;92:1780-6; discussion 1786

[29] Kane JM,Driscoll D,Gibbs JF.The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases.Sarcoma2002;6:69-73 PMCID:PMC2395477